ARTICLE | Clinical News
MabThera regulatory update
April 25, 2011 7:00 AM UTC
Roche disclosed in its 1Q11 earnings that it submitted an application in Switzerland for MabThera rituximab to treat antineutrophil cytoplasmic antibody (ANCA)-associated renal vasculitis. MabThera is...